|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.593
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.463
|
Mouse |
|
|
cytokine production
|
GO:0001816 |
319 |
0.356
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.356
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.346
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.339
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.317
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.290
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.273
|
Mouse |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.264
|
Mouse |
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.261
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.251
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.251
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.247
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.236
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.223
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.206
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.201
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.194
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.189
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.170
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.169
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.160
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.141
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.135
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.132
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.130
|
|
|
|
phototransduction
|
GO:0007602 |
17 |
0.130
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.128
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.127
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.123
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.121
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.113
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.111
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.109
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.107
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.107
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.104
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.103
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.102
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.100
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.097
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.097
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.096
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.096
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.096
|
Mouse |
|
|
response to radiation
|
GO:0009314 |
165 |
0.094
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.091
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.089
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.088
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.086
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.083
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.083
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.081
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.081
|
Mouse |
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.080
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.078
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.076
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.076
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.075
|
|
|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.074
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.072
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.071
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.070
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.070
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.070
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.070
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.069
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.069
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.069
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.068
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.068
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.068
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.068
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.066
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.066
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.066
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.065
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.065
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.065
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.065
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.064
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.063
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.063
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.062
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.062
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.061
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.061
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.061
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.061
|
Mouse |
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.061
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.061
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.060
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.060
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.059
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.059
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.059
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.059
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.059
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.059
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.058
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.057
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.057
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.057
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.056
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.056
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.056
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.056
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.056
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.055
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.054
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.054
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.054
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.054
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.053
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.053
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.053
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.052
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.052
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.052
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.052
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.051
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.051
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.050
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.050
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.050
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.050
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.050
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.049
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.049
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.049
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.049
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.048
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.048
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.048
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.048
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.047
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.047
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.047
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.047
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.046
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.046
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.045
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.045
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.045
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.045
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.045
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.045
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.045
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.045
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.044
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.044
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.044
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.044
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.044
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.044
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.043
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.043
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.042
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.042
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.041
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.041
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.041
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.041
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.040
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.040
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.040
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.040
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.040
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.040
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.040
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.040
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.040
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.040
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.039
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.039
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.039
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.039
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.039
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.038
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.038
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.038
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.037
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.037
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.037
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.037
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.036
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.036
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.036
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.036
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.036
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.035
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.035
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.035
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.035
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.035
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.035
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.035
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.035
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.034
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.034
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.034
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.034
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.034
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.034
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.033
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.033
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.033
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.033
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.032
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.032
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.032
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.032
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.032
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.032
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.032
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.032
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.032
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.032
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.032
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.031
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.031
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.031
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.031
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.031
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.031
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.031
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.031
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.031
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.030
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.030
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.030
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.030
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.030
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.030
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.030
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.030
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.029
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.029
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.029
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.029
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.029
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.029
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.029
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.029
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.029
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.028
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.028
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.028
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.028
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.027
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.027
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.027
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.027
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.027
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.027
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.027
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.027
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.027
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.027
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.027
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.027
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.027
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.027
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.026
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.026
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.026
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.026
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.026
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.026
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.026
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.026
|
|
|
|
detection of visible light
|
GO:0009584 |
14 |
0.026
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.026
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.026
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.026
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.026
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.026
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.025
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.025
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.025
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.025
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.025
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.025
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.025
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.025
|
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.025
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.025
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.024
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.024
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.024
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.024
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.024
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.024
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.024
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.024
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.024
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.024
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.023
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.023
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.023
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.023
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.022
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.022
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.022
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.022
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.022
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.022
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.022
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.022
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.022
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.022
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.021
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.021
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.021
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.021
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.021
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.021
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.021
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.021
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.021
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.020
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.020
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.020
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.020
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.020
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.020
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.020
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.020
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.020
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.020
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.020
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.020
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.020
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.020
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.020
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.020
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.020
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.020
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.020
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.020
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.020
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.020
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.020
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.019
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.019
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.019
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.019
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.019
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.019
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.019
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.019
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.019
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.019
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.019
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.019
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.019
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.019
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.019
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
9 |
0.019
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.019
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.019
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.018
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.018
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.018
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
10 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.018
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.018
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.018
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.018
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.018
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.018
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.018
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.018
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.018
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.018
|
|
|
|
establishment of meiotic spindle orientation
|
GO:0051296 |
1 |
0.017
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.017
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.017
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.017
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.017
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.017
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.017
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.017
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.017
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.017
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.017
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.017
|
|
|
|
metanephric thick ascending limb development
|
GO:0072233 |
2 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.017
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.016
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.016
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.016
|
|
|
|
cgmp catabolic process
|
GO:0046069 |
2 |
0.016
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.016
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.016
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.016
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.016
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.016
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.016
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.016
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.016
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.016
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.016
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.016
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.016
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.016
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.016
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.016
|
|
